Patent intelligence · US
US 11707434
Method for preparing organic solvent-free lyophilized cyclophosphamide
Method for preparing organic solvent-free lyophilized cyclophosphamide
Patent details — US 11707434
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 25, 2023
- Expiration
- Jul 20, 2043
- Applicant
- KOREA UNITED PHARM. INC.
- Claims
- 18
- CPC classes
- A61K, A61K31/675, A61K47/26, A61K9/0019
Quick answer
US 11707434 (Method for preparing organic solvent-free lyophilized cyclophosphamide) is held by KOREA UNITED PHARM. INC.. Status: granted. Granted Jul 25, 2023. Expires Jul 20, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- KOREA UNITED PHARM. INC.
- Grant date
- Expiration
- Claims
- 18
- CPC classes
- A61K, A61K31/675, A61K47/26, A61K9/0019, A61K9/19
More from KOREA UNITED PHARM. INC.
Related pharmaceutical patents in our USPTO index.
-
US 12419873
Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases
granted -
US 12419941
Poultry drinking water-based vaccine delivery system and method
granted -
US 12415845
Methods of producing T cell populations using hydroxycitric acid and/or a salt thereof
granted -
US 12410240
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
granted -
US 12410259
CD47 targeted therapies for the treatment of infectious disease
granted -
US 12404317
T cell receptors recognizing MHC class II-restricted MAGE-A3
granted -
US 12397066
Delivery of gene therapy treatments
granted -
US 12398123
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria
granted
Frequently asked questions
What is US patent 11707434?
US 11707434 (Method for preparing organic solvent-free lyophilized cyclophosphamide) is held by KOREA UNITED PHARM. INC.. Status: granted. Granted Jul 25, 2023. Expires Jul 20, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11707434?
KOREA UNITED PHARM. INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3,720 pharmaceutical patents for this assignee.
When does US 11707434 expire?
Our index shows an expiration date of Jul 20, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.